Advances in the design and development of oncolytic measles viruses

od Hutzen, Brian, Raffel, Corey, Studebaker, Adam W
Wydane w Oncolytic Virother (2015)

Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid–disseminated medulloblastoma

od Studebaker, Adam W., Hutzen, Brian, Pierson, Christopher R., Russell, Stephen J., Galanis, Evanthia, Raffel, Corey
Wydane 2012

Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine

od Hutzen, Brian, Pierson, Christopher R, Russell, Stephen J, Galanis, Evanthia, Raffel, Corey, Studebaker, Adam W
Wydane 2012

EphB2 activation is required for ependymoma development as well as inhibits differentiation and promotes proliferation of the transformed cell

od Chen, Phylip, Rossi, Nathan, Priddy, Samuel, Pierson, Christopher R., Studebaker, Adam W., Johnson, Robert A.
Wydane w Sci Rep (2015)

Treatment of medulloblastoma with a modified measles virus

od Studebaker, Adam W., Kreofsky, Cole R., Pierson, Christopher R., Russell, Stephen J., Galanis, Evanthia, Raffel, Corey
Wydane 2010

Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumors

od Studebaker, Adam W., Hutzen, Brian, Pierson, Christopher R., Shaffer, Terri A., Raffel, Corey, Jackson, Eric M.
Wydane w Neuro Oncol (2015)

Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin

od Hutzen, Brian, Bid, Hemant Kumar, Houghton, Peter J, Pierson, Christopher R, Powell, Kimerly, Bratasz, Anna, Raffel, Corey, Studebaker, Adam W
Wydane 2014

Oncolytic Herpes Virus rRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and Atypical Teratoid/Rhabdoid Tumors

od Studebaker, Adam W., Hutzen, Brian J., Pierson, Christopher R., Haworth, Kellie B., Cripe, Timothy P., Jackson, Eric M., Leonard, Jeffrey R.
Wydane w Mol Ther Oncolytics (2017)

ΔNp73/ETS2 complex drives glioblastoma pathogenesis— targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma

od Cam, Maren, Charan, Manish, Welker, Alessandra M, Dravid, Piyush, Studebaker, Adam W, Leonard, Jeffrey R, Pierson, Christopher R, Nakano, Ichiro, Beattie, Christine E, Hwang, Eugene I, Kambhampati, Madhuri, Nazarian, Javad, Finlay, Jonathan L, Cam, Hakan
Wydane w Neuro Oncol (2020)